Recon: FDA Approves J&J's Antidepressant Nasal Spray; Vertex's Second Triple-Drug CF Combo Hits Phase III Goals - Regulatory Focus

Recon: FDA Approves J&J's Antidepressant Nasal Spray; Vertex's Second Triple-Drug CF Combo Hits Phase III Goals  Regulatory FocusWelcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Gottlieb to Resign as FDA Commissioner (Focus) ...